Skip to main content
University of California San Francisco
UCSF School of Medicine | Department of Pediatrics UCSF Medical Center

Clinical and Neurophysiological Phenotypes in Neonates With BRAT1 Encephalopathy.

  • Read more about Clinical and Neurophysiological Phenotypes in Neonates With BRAT1 Encephalopathy.

Therapeutic Response in Pediatric Neuromyelitis Optica Spectrum Disorder.

  • Read more about Therapeutic Response in Pediatric Neuromyelitis Optica Spectrum Disorder.

The ALIGN Framework: A Parent-Informed Approach to Prognostic Communication for Infants With Neurologic Conditions.

  • Read more about The ALIGN Framework: A Parent-Informed Approach to Prognostic Communication for Infants With Neurologic Conditions.

The State of Inpatient Child Neurology: A Survey of North American Academic Programs.

  • Read more about The State of Inpatient Child Neurology: A Survey of North American Academic Programs.

Interim Analysis of Long-Term Safety and Efficacy of FINTEPLA (fenfluramine) in Patients with Lennox-Gastaut Syndrome (S13.010).

  • Read more about Interim Analysis of Long-Term Safety and Efficacy of FINTEPLA (fenfluramine) in Patients with Lennox-Gastaut Syndrome (S13.010).

Fenfluramine Improves Everyday Executive Functioning in Patients With Lennox-Gastaut Syndrome: Analysis of Phase 3 Data (P12-8.004).

  • Read more about Fenfluramine Improves Everyday Executive Functioning in Patients With Lennox-Gastaut Syndrome: Analysis of Phase 3 Data (P12-8.004).

Clinical Reasoning: A 2-Day-Old Boy With Sudden Cardiac Arrest and Encephalopathy.

  • Read more about Clinical Reasoning: A 2-Day-Old Boy With Sudden Cardiac Arrest and Encephalopathy.

Seizure Control in Neonates Undergoing Screening vs Confirmatory EEG Monitoring.

  • Read more about Seizure Control in Neonates Undergoing Screening vs Confirmatory EEG Monitoring.

Reader response: Child neurology in the 21st century: More than the sum of our RVUs.

  • Read more about Reader response: Child neurology in the 21st century: More than the sum of our RVUs.

Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension.

  • Read more about Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension.

Pagination

  • Previous page ‹‹
  • Page 3
  • Next page ››
Subscribe to Neurology

Pediatrics Home

MAKE A GIFT

© 2022 The Regents of the University of California. The University of California San Francisco  |  UCSF Department of Pediatrics                                                                                              Accessibility  Privacy Policy  Terms of Use  A-Z Website List